STANDARD BIOTOOLS INC. — Director's Dealing 2012

Feb 22, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2012-02-17

Reporting Person: Smith William Maxwell (EVP, Legal Affairs & GC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-17	Common Stock	M	2340	$1.82	Acquired	51885	Direct
2012-02-17	Common Stock	S	2340	$15.6004	Disposed	49545	Direct
2012-02-21	Common Stock	M	660	$1.82	Acquired	50205	Direct
2012-02-21	Common Stock	S	660	$15.6004	Disposed	49545	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-17	Employee Stock Option (Right to Buy)	$1.82	M	2340	Disposed	2013-07-15	Common Stock (2340)	Direct
2012-02-17	Employee Stock Option (Right to Buy)	$15.49	A	70000	Acquired	2022-02-16	Common Stock (70000)	Direct
2012-02-21	Employee Stock Option (Right to Buy)	$1.82	M	660	Disposed	2013-07-15	Common Stock (660)	Direct

Footnotes

F1: The sales reported by Mr. Smith were effected pursuant to a Rule 10b5-1 trading plan adopted on September 6, 2011.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $15.6000 to $15.6125, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: The shares were to be sold on February 17, 2012. Due to a trading error, these shares were not sold until February 21, 2012 at a price per share of $14.75; however, the Reporting Person will receive proceeds based upon a sale price of $15.6004, the weighted-average price per share of shares sold on February 17, 2012.

F4: The Option fully vested on April 1, 2007.

F5: 1/48 of the shares subject to the Option vested on the date of grant and 1/48 of the shares subject to the Option will vest on March 1, 2012 and each month thereafter, such that the option will be fully vested on January 1, 2016.